Helen Frankenthaler PCB Circuit Board R&D Center

infrared phototherapy cap pcba reliability

Red and Near Infrared Light Therapy: Safety and Effectiveness

Our Members Asked:

Does red and near infrared light therapy reduce pain, improve skin or cognition, or have other benefits? Is it safe?

Answer:

Red and near infrared (NIR) light therapy, also known as photobiomodulation, involves exposing skin to low level wavelengths of red light (usually 600 to 680 nm) or NIR light (typically 800 to 850 nm) using light emitting diodes (LEDs) or lasers.

Although red and NIR light therapy devices have been evaluated in clinical research for numerous conditions, with some positive results, in general there is not enough available information to recommend these devices for any specific condition.

Nevertheless, the FDA has "cleared" some of these devices for specific uses — but the review process for FDA clearance is not the same for FDA approval, which requires more rigorous evaluation of safety and effectiveness. Also be aware that some devices sold for at-home use may not be as powerful as those used in the clinical studies discussed in this article.

Sign in as a member for details about evidence for and against red and NIR light therapy for conditions including acne, actinic keratosis (rough, scaly patches on the skin caused by long-term sun exposure), reducing skin aging, vitiligo, cold sores (herpes simplex infection), hair loss, knee osteoarthritis, fibromyalgia, jaw pain, plantar fasciitis (a common cause of pain in the heel and bottom of the foot), nerve pain (neuropathy), cognition among healthy adults and those with mild cognitive impairment (MCI), Alzheimer's disease or dementia, Parkinson's disease, and eye conditions including age-related macular degeneration (AMD) and myopia (nearsightedness). Also learn about specific products on the market (including BIOMAX 900, FibroLux, MOVE+ Pro, Omnilux Contour Face Mask, PainAway, TenDlite, and Valeda) and possible safety issues, including eye damage and appropriate eye protection.

(Note: ConsumerLab has not tested red or NIR light therapy devices to confirm the accuracy of label claims of these devices.)

Sources

In addition the results of its expert testing, ConsumerLab uses only high-quality, evidence based, information sources. These sources include peer-reviewed studies and information from agencies such as the FDA and USDA, and the National Academy of Medicine. On evolving topics, studies from pre-print journals may be sourced. All of our content is reviewed by medical doctors and doctoral-level experts in pharmacology, toxicology, and chemistry. We continually update and medically review our information to keep our content trustworthy, accurate, and reliable. The following sources are referenced in this article:

  • AAD Association, 9/13/2024
  • Aboy, npj Digital Medicine 2024
  • Al-Quisi, Pan Res Treat 2019
  • Ameluz Topical Gel 10%, Prescribing Information
  • Ameluz Topical Gel 10%, Prescribing Information
  • Avci, Semin Cutan Med Surg 2013
  • Berman, J Neurol Neurosci 2017
  • Boyer, Retina 2024
  • CMS.gov, 10/24/06
  • Chao, Photobiomodul Photomed Laser Surg 2019
  • Cinar, Lasers Med Sci 2018
  • Claes, Eur J Neurol 2023
  • Eisen, J Am Acad Dermatol 2021
  • Ershadi, research letter in JAMA Derm 2025
  • FDA, 11/4/2024
  • FDA, 21CFR890.5500
  • FDA, 7/28/2014
  • FDA, Product Classification; Updated 7-15-2024
  • Gomes, Laser Surg Med 2018
  • Grewal, J Clin Med 2020
  • Heiskanen, Photochem Photobiol Sci 2019
  • Herkes, eClinicalMedicine 2023
  • Higgins, J Chiropr Med 2015
  • Jagdeo, J Biophotonics 2020
  • Joovv Go 2.0
  • Joshi, J Biophotonics 2024
  • Ketz, Int J Sports Phys Ther 2024
  • Liebert, BMC Neurol 2021
  • Liebert, BMC Neurol 2024
  • Lopes-Martins, Proc. SPIE 6140 2006
  • McGee, J Clin Med 2023